193 related articles for article (PubMed ID: 7731022)
1. Synthesis and in vivo evaluation of prodrugs of 9-[2-(phosphonomethoxy)ethoxy]adenine.
Serafinowska HT; Ashton RJ; Bailey S; Harnden MR; Jackson SM; Sutton D
J Med Chem; 1995 Apr; 38(8):1372-9. PubMed ID: 7731022
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, oral bioavailability determination, and in vitro evaluation of prodrugs of the antiviral agent 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA).
Starrett JE; Tortolani DR; Russell J; Hitchcock MJ; Whiterock V; Martin JC; Mansuri MM
J Med Chem; 1994 Jun; 37(12):1857-64. PubMed ID: 8021925
[TBL] [Abstract][Full Text] [Related]
3. Metabolism and pharmacokinetics of novel oral prodrugs of 9-[(R)-2-(phosphonomethoxy)propyl]adenine (PMPA) in dogs.
Shaw JP; Sueoko CM; Oliyai R; Lee WA; Arimilli MN; Kim CU; Cundy KC
Pharm Res; 1997 Dec; 14(12):1824-9. PubMed ID: 9453075
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, in vitro antiviral evaluation, and stability studies of bis(S-acyl-2-thioethyl) ester derivatives of 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA) as potential PMEA prodrugs with improved oral bioavailability.
Benzaria S; Pélicano H; Johnson R; Maury G; Imbach JL; Aubertin AM; Obert G; Gosselin G
J Med Chem; 1996 Dec; 39(25):4958-65. PubMed ID: 8960556
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the disposition of ester prodrugs of the antiviral agent 9-(2-phosphonylmethoxyethyl)adenine [PMEA] in Caco-2 monolayers.
Annaert P; Gosselin G; Pompon A; Benzaria S; Valette G; Imbach JL; Naesens L; Hatse S; de Clercq E; Van den Mooter G; Kinget R; Augustijns P
Pharm Res; 1998 Feb; 15(2):239-45. PubMed ID: 9523310
[TBL] [Abstract][Full Text] [Related]
6. Antiretroviral activity and pharmacokinetics in mice of oral bis(pivaloyloxymethyl)-9-(2-phosphonylmethoxyethyl)adenine, the bis(pivaloyloxymethyl) ester prodrug of 9-(2-phosphonylmethoxyethyl)adenine.
Naesens L; Balzarini J; Bischofberger N; De Clercq E
Antimicrob Agents Chemother; 1996 Jan; 40(1):22-8. PubMed ID: 8787873
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of 9-[1-(1 -hydroxyethyl)-3-(phosphonomethoxy)propyl]adenine and prodrug as possible antiviral agents.
Ghosh A; El-Kattan Y; Wu M; Lin TH; Vadlakonda S; Kotian PL; Babu YS; Chand P
Nucleosides Nucleotides Nucleic Acids; 2005; 24(10-12):1587-95. PubMed ID: 16438036
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and in vitro evaluation of a phosphonate prodrug: bis(pivaloyloxymethyl) 9-(2-phosphonylmethoxyethyl)adenine.
Starrett JE; Tortolani DR; Hitchcock MJ; Martin JC; Mansuri MM
Antiviral Res; 1992 Sep; 19(3):267-73. PubMed ID: 1332606
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of novel bis(L-amino acid) ester prodrugs of 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA) with improved anti-HBV activity.
Fu X; Jiang S; Li C; Xin J; Yang Y; Ji R
Bioorg Med Chem Lett; 2007 Jan; 17(2):465-70. PubMed ID: 17074481
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of ester prodrugs of 9-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]-2,6-diaminopurine (HPMPDAP) as anti-poxvirus agents.
Krecmerová M; Holý A; Andrei G; Pomeisl K; Tichý T; Brehová P; Masojídková M; Dracínský M; Pohl R; Laflamme G; Naesens L; Hui H; Cihlar T; Neyts J; De Clercq E; Balzarini J; Snoeck R
J Med Chem; 2010 Oct; 53(19):6825-37. PubMed ID: 20809641
[TBL] [Abstract][Full Text] [Related]
11. Prodrugs of the selective antiherpesvirus agent 9-[4-hydroxy-3-(hydroxymethyl)but-1-yl]guanine (BRL 39123) with improved gastrointestinal absorption properties.
Harnden MR; Jarvest RL; Boyd MR; Sutton D; Vere Hodge RA
J Med Chem; 1989 Aug; 32(8):1738-43. PubMed ID: 2754699
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological properties of prodrugs of (S)-3-(adenin-9-yl)-2-(phosphonomethoxy)propanoic acid.
Kaiser MM; Poštová-Slavětínská L; Dračínský M; Lee YJ; Tian Y; Janeba Z
Eur J Med Chem; 2016 Jan; 108():374-380. PubMed ID: 26706348
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine-based 1-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]cytosine and -adenine ((S)-HPMPC and (S)-HPMPA) prodrugs: synthesis, stability, antiviral activity, and in vivo transport studies.
Zakharova VM; Serpi M; Krylov IS; Peterson LW; Breitenbach JM; Borysko KZ; Drach JC; Collins M; Hilfinger JM; Kashemirov BA; McKenna CE
J Med Chem; 2011 Aug; 54(16):5680-93. PubMed ID: 21812420
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of 9-[1-(substituted)-3-(phosphonomethoxy)propyl]adenine derivatives as possible antiviral agents.
Wu M; El-Kattan Y; Lin TH; Ghosh A; Vadlakonda S; Kotian PL; Babu YS; Chand P
Nucleosides Nucleotides Nucleic Acids; 2005; 24(10-12):1543-68. PubMed ID: 16438034
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of salicylate ester prodrugs of cyclic HPMPC in dogs.
Oliyai R; Arimilli MN; Jones RJ; Lee WA
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):1411-4. PubMed ID: 11563033
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and metabolism of selected prodrugs of PMEA in rats.
Shaw JP; Louie MS; Krishnamurthy VV; Arimilli MN; Jones RJ; Bidgood AM; Lee WA; Cundy KC
Drug Metab Dispos; 1997 Mar; 25(3):362-6. PubMed ID: 9172955
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antiviral evaluation of 9-(S)-[3-alkoxy-2-(phosphonomethoxy)propyl]nucleoside alkoxyalkyl esters: inhibitors of hepatitis C virus and HIV-1 replication.
Valiaeva N; Wyles DL; Schooley RT; Hwu JB; Beadle JR; Prichard MN; Hostetler KY
Bioorg Med Chem; 2011 Aug; 19(15):4616-25. PubMed ID: 21719300
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of 9-[1-(substituted)-2-(phosphonomethoxy)ethyl]adenine derivatives as possible antiviral agents.
Wu M; El-Kattan Y; Lin TH; Ghosh A; Kumar VS; Kotian PL; Cheng X; Bantia S; Babu YS; Chand P
Nucleosides Nucleotides Nucleic Acids; 2005; 24(10-12):1569-85. PubMed ID: 16438035
[TBL] [Abstract][Full Text] [Related]
19. [Design, synthesis and anti-hBV evaluation of adefovir mono-L-amino acid ester, mono non-steroidal anti-inflammatory drugs carboxylic ester prodrugs].
Fu XZ; Wang YL; Lan YY; Wang AM; Ou Y; Luo C; Li Y
Yao Xue Xue Bao; 2010 Aug; 45(8):1017-24. PubMed ID: 21351588
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of intestinal metabolism of the antiviral ester prodrug bis(POC)-PMPA by nature-identical fruit extracts as a strategy to enhance its oral absorption: an in vitro study.
Van Gelder J; Annaert P; Naesens L; De Clercq E; Van den Mooter G; Kinget R; Augustijns P
Pharm Res; 1999 Jul; 16(7):1035-40. PubMed ID: 10450927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
